These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 7646826)
1. A risk-benefit assessment of zidovudine in the prevention of perinatal HIV transmission. Newell ML; Gibb DM Drug Saf; 1995 Apr; 12(4):274-82. PubMed ID: 7646826 [TBL] [Abstract][Full Text] [Related]
2. Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection. Bhana N; Ormrod D; Perry CM; Figgitt DP Paediatr Drugs; 2002; 4(8):515-53. PubMed ID: 12126455 [TBL] [Abstract][Full Text] [Related]
3. Effect of zidovudine treatment in late pregnancy on HIV-1 in utero transmission. Taneepanichskul S; Sirinavin S; Phuapradit W; Chaturachinda K Aust N Z J Obstet Gynaecol; 1997 Aug; 37(3):329-31. PubMed ID: 9325519 [TBL] [Abstract][Full Text] [Related]
4. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. ; de Vincenzi I Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718 [TBL] [Abstract][Full Text] [Related]
5. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569 [TBL] [Abstract][Full Text] [Related]
6. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118 [TBL] [Abstract][Full Text] [Related]
7. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Recomm Rep; 1994 Aug; 43(RR-11):1-20. PubMed ID: 7913986 [TBL] [Abstract][Full Text] [Related]
8. [Preventing the transmission of HIV-1 from mother to child in Africa in the year 2000]. Castetbon K; Leroy V; Spira R; Dabis F Sante; 2000; 10(2):103-13. PubMed ID: 10960807 [TBL] [Abstract][Full Text] [Related]
9. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. Lallemant M; Jourdain G; Le Coeur S; Kim S; Koetsawang S; Comeau AM; Phoolcharoen W; Essex M; McIntosh K; Vithayasai V N Engl J Med; 2000 Oct; 343(14):982-91. PubMed ID: 11018164 [TBL] [Abstract][Full Text] [Related]
10. HIV infection and zidovudine use in childbearing women. Sia J; Paul S; Martin RM; Cross H Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619 [TBL] [Abstract][Full Text] [Related]
11. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654 [TBL] [Abstract][Full Text] [Related]
12. [The reduction of mother-child transmission of HIV infection in developing countries: potential intervention strategies, obstacles to implementation and perspectives. The Reduction of Mother-Child Transmission of HIV Infection in Africa Group]. Meda N; Msellati P; Welffens-Ekra C; Cartoux M; Leroy V; Van de Perre P; Salamon R Sante; 1997; 7(2):115-25. PubMed ID: 9273118 [TBL] [Abstract][Full Text] [Related]
13. Short course of AZT halves HIV-1 perinatal transmission. Morris K Lancet; 1998 Feb; 351(9103):651. PubMed ID: 9500334 [TBL] [Abstract][Full Text] [Related]
14. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M; JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785 [TBL] [Abstract][Full Text] [Related]
15. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission. Briand N; Le Coeur S; Traisathit P; Karnchanamayul V; Hansudewechakul R; Ngampiyasakul C; Bhakeecheep S; Ithisukanan J; Hongsiriwon S; McIntosh K; Lallemant M Pediatr Infect Dis J; 2006 Apr; 25(4):325-32. PubMed ID: 16567984 [TBL] [Abstract][Full Text] [Related]
16. Zidovudine for the prevention of HIV transmission from mother to infant. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1994 Apr; 43(16):285-7. PubMed ID: 8159153 [TBL] [Abstract][Full Text] [Related]
17. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era? Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S; Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147 [TBL] [Abstract][Full Text] [Related]
18. Bringing AZT to poor countries. Cohen J Science; 1995 Aug; 269(5224):624-6. PubMed ID: 7624786 [No Abstract] [Full Text] [Related]
19. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial. Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S; Clin Infect Dis; 2015 Jul; 61(2):270-80. PubMed ID: 25838291 [TBL] [Abstract][Full Text] [Related]